Cargando…
Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
Gut mycobiota inhabits human gastrointestinal lumen and plays a role in human health and disease. We investigated the influence of proton pump inhibitors (PPIs) on gastric mucosal and fecal mycobiota in patients with gastroesophageal reflux diseases (GERD) by using Internal Transcribed Spacer 1 sequ...
Autores principales: | Shi, Yichao, Li, Jianfeng, Cai, Shuntian, Zhao, Hong, Zhao, Huijun, Sun, Gang, Yang, Yunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469693/ https://www.ncbi.nlm.nih.gov/pubmed/37662013 http://dx.doi.org/10.3389/fcimb.2023.1205348 |
Ejemplares similares
-
Commentary: The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study
por: Drall, Kelsea M., et al.
Publicado: (2018) -
Analysis of the gut microbiota in children with gastroesophageal reflux disease using metagenomics and metabolomics
por: Ye, Xiaolin, et al.
Publicado: (2023) -
Effects of Helicobacter pylori eradication on esophageal motility, esophageal acid exposure, and gastroesophageal reflux disease symptoms
por: Zhao, Tong, et al.
Publicado: (2023) -
Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019) -
The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux—A Prospective Longitudinal Interventional Study
por: Castellani, Christoph, et al.
Publicado: (2017)